Aurinia Pharmaceuticals' (AUPH) CEO Bought 815,000 Shares for $12.5 Million

814,606 common shares were acquired for approximately $12.5 million at a weighted average price of $15.29 per share. The purchase represented 6.66% of Kevin Tang's pre-transaction holdings, while direct ownership remained unchanged at zero shares post-transaction. The disclosure is largely factual and should have limited near-term market impact.

Analysis

814,606 common shares were acquired for approximately $12.5 million at a weighted average price of $15.29 per share. The purchase represented 6.66% of Kevin Tang's pre-transaction holdings, while direct ownership remained unchanged at zero shares post-transaction. The disclosure is largely factual and should have limited near-term market impact.